When EU Regulations Change, Do You Need to Update Your CPSR Immediately? (Real Compliance Scenarios)

Most cosmetic brands think their CPSR is done once the product launches. But under EU cosmetic law, that is not how compliance works. EU regulation changes happen all the time, and even a small formula change, packaging update, or new SCCS opinion can affect your cosmetics assessment and require a CPSR update.

If your documents do not match the latest rules, your product may fail CPSR compliance, even if the formula has stayed the same. That is why CPSR validity depends on keeping your safety documents updated at all times.

That means your CPSR may require updates when:

• • EU Annex restrictions change

• • SCCS safety opinions are published

• • Ingredient concentration limits are lowered

• • Packaging materials change

• • Product use conditions change

• • Fragrance allergen rules expand

• • Formula modifications occur

• • New scientific safety data becomes available

Even if your formula stays exactly the same, your cosmetic safety assessment can still become outdated under EU law.

Smart brands do not wait for inspections or enforcement action. They review their cosmetic safety assessment regularly and stay updated on EU regulation changes to keep selling safely in the EU market.

This guide shows you when you need to take action, what risks you should look out for, and how brands keep their products compliant with EU rules. 

What Is a CPSR and What Does EU Cosmetic Law Actually Require?

A Cosmetic Product Safety Report (CPSR) is a mandatory legal document required under EU Regulation (EC) No 1223/2009. Every cosmetic product sold on the EU market must have one. It is not a one-time certificate. It is a live technical document that must stay accurate for as long as your product is on shelves.

The cosmetic safety report has two legally binding parts:

Part A: Safety information: This includes your formula, ingredient toxicology, microbiological data, packaging details, and stability results.

Part B: The Safety Assessor’s conclusion: This is the qualified assessor’s signed statement that your product is safe for its intended use.

Here is the critical point. Part B cannot be updated by the brand. Every meaningful change requires the assessor’s personal review and re-signature. So when EU regulations change and affect anything in Part A or Part B, the report becomes inaccurate. And an inaccurate CPSR means a non-compliant product, full stop.

Cosmetic Safety Assessment and Ongoing Compliance Obligations 

This is one of the most expensive misconceptions in EU cosmetics compliance. A cosmetic safety assessment is an ongoing legal obligation, not a box you tick at launch.

The regulation is clear. Your Product Information File (PIF), which contains your CPSR, must stay current throughout the product’s entire market lifecycle. There is no “permanent compliance” clause.

Here is a simple example of why that matters:

• • An ingredient in your formula gets moved to Annex III with a lower concentration limit.

• • Your CPSR was written before that change.

• • Your formula has not changed at all.

• • But your documentation is now inaccurate, and that makes your product non-compliant.

Formula Changes and CPSR Compliance Updates 

Any formula modification, doesn’t matter how minor it feels, requires a fresh review of your cosmetic safety assessment. When a formula change happens, the Safety Assessor must:

• • Review new ingredient toxicology data

• • Recalculate consumer exposure levels

• • Check the updated formula against current EU Annex restrictions

• • Re-sign Part B with updated conclusions

Brands often treat formula tweaks as simple operational decisions. A preservative swap driven by supply chain convenience feels routine. But from a regulatory standpoint, it introduces a different chemical into a product whose CPSR was built around the original formula. There is no shortcut here. Selling the reformulated product before the assessor’s review is complete is a direct compliance breach under EU cosmetic law.

EU Cosmetics Annex Updates and CPSR Compliance Impact 

The EU Cosmetics Regulation works through a system of Annexes. Each Annex governs a different category of ingredient status. Understanding how each Annex affects your CPSR compliance is essential for any brand selling in the EU.

When an ingredient moves to Annex II, you have no choice. The product must be reformulated or withdrawn before the regulation’s application date. When an ingredient is added to Annex III with new concentration limits, your Safety Assessor must confirm whether your current formula still complies, update Part A to reflect the new regulatory status, and revise Part B if their safety conclusion changes.

Neither situation allows for a wait-and-see approach. The obligation is immediate and your documentation must reflect it.

Beyond formal Annex amendments, the scientific landscape can shift your compliance picture just as significantly.

How New Scientific Data and SCCS Opinions Trigger CPSR Updates 

EU cosmetic law does not only change through formal Annex amendments. The Scientific Committee on Consumer Safety (SCCS) regularly publishes scientific opinions on cosmetic ingredients. Those opinions carry real legal weight for your cosmetic safety assessment.

When the SCCS publishes a new opinion, it can trigger a CPSR update in several ways:

• • A previously accepted ingredient concentration gets lowered based on new safety evidence

• • New conditions of use are introduced, specific pH ranges, rinse-off only, or age restrictions

• • An ingredient previously considered safe gets flagged for further restriction or monitoring

• • New exposure data changes how consumer risk is calculated for a substance in your formula

Your Safety Assessor must review that new data and assess whether it changes their Part B conclusions. The regulation is important; your cosmetic product safety assessment must reflect the current state of scientific knowledge, not just what was known when the report was first written.

A proactive assessor flags new SCCS opinions as they are published. A less engaged one may not. That gap is exactly why brands need to monitor SCCS publications themselves, or work with assessors who include ongoing regulatory monitoring in their service.

How Changes in Use Conditions Affect CPSR Compliance (Same Formula) 

One of the most overlooked triggers for a CPSR update is a change in how your product is used, or who uses it, even when the formula stays completely identical.

Every cosmetic safety assessment is built around a specific exposure model. That model depends on several factors:

Change any of these and the exposure model changes with it, and so do the safety conclusions your assessor originally signed off on. Here are the scenarios that come up most often:

1. 1. Rinse-off to leave-on: This increases dermal absorption significantly and requires a full reassessment.

1. 1. Adult to child audience: This triggers stricter safety thresholds across every single ingredient in your formula.

1. 1. Weekly to daily use: This raises cumulative consumer exposure beyond what the original CPSR modelled.

1. 1. New application site: Face products and body products carry different absorption and risk profiles.

In every one of these cases, the product requires a new cosmetic product safety assessment before it can legally be marketed under the new conditions.

Real 2025–2026 CPSR Compliance Scenarios in EU Cosmetics 

Recent EU cosmetic regulation changes are creating major compliance obligations for cosmetic brands across Europe.

Several important updates are already affecting CPSR reviews.

These include:

• • Omnibus VIII ingredient restrictions

• • Expanded fragrance allergen labeling

• • Updated INCI naming requirements

• • Formaldehyde releaser restrictions

• • New SCCS toxicological opinions

• • Annex III concentration revisions

Brands ignoring these developments risk selling products with outdated CPSRs. 

Omnibus VIII (May 2026): Ingredient Restrictions

EU Cosmetics Omnibus VIII is the most significant recent change affecting CPSR compliance across Europe. Its application date is 1 May 2026. It amends the Annexes to restrict or prohibit a range of substances, including newly classified CMR substances (Carcinogenic, Mutagenic, or Toxic to Reproduction) that have been moved to Annex II.

If your formula contains an affected ingredient, the obligation is immediate. Here is what needs to happen:

1. 1. Cross-check your full INCI list against the Omnibus VIII amendments right now

1. 1. Contact your Safety Assessor to review affected ingredients before the application date

1. 1. Begin the CPSR update process; do not wait until reformulation is finished

1. 1. Update your CPNP notification to reflect any formula changes

1. 1. Version and date your updated CPSR to clearly show post-Omnibus VIII compliance

Selling a product after 1 May 2026 with a prohibited ingredient, and a CPSR that predates the restriction, is a direct breach of EU cosmetic law. National market surveillance authorities can require immediate withdrawal. That is not a technicality.

Preservative Restrictions as an Annex III 

Formaldehyde-releasing preservatives have faced tightening EU restrictions for years. Say your formula uses one of these preservatives at a concentration that was previously compliant. A new Annex III amendment lowers the maximum permitted level. Now your cosmetic safety assessment needs to respond.

Two outcomes are possible, and neither is simple.

Scenario 1: Your Formula Still Meets the New Limit 

You do not need to reformulate. But your CPSR still needs updating. The report must reference the new regulatory status and confirm that your formula remains compliant under the amended Annex III limit. Your Safety Assessor must review Part A and re-sign Part B to reflect the current regulatory picture.

Scenario 2: Your Formula Exceeds the New Limit 

This is the more serious scenario. You must reformulate the product to bring the preservative concentration within the new permitted level. Once reformulated, you need to generate new stability and microbiological data for the updated formula. Only then can your assessor commission a fully updated cosmetic product safety assessment. You cannot continue to sell until that process is complete.

Scenario 3: Deadlines Cannot Be Ignored 

Neither outcome can be handled after the application date has passed. The clock starts the moment the amendment takes effect, not the moment you discover it. 

Brands that wait until the deadline approaches often find themselves unable to complete the assessor review, generate new data, and update their CPSR in time. Start the process as soon as the amendment is published.

Fragrance Allergen Labelling (EU 2023/1545) and Its Impact 

EU Regulation 2023/1545 expanded the list of declarable fragrance allergens from 26 to 80 substances. The implementation timeline is now active for new products. This is primarily a labelling change, but its impact on your CPSR cosmetics documentation is real and frequently underestimated.

The thresholds that trigger labelling requirements are:

• • 0.001% in leave-on products

• • 0.01% in rinse-off products

If any newly listed allergen in your fragrance sits above these thresholds, it must appear on your label. But here is where your CPSR assessment gets pulled in directly. If you choose to reformulate the fragrance to bring allergen levels below the threshold, that decision triggers a full formula change review. 

Your assessor will need updated fragrance documentation, new toxicology data for the revised blend, a revised Part A, and an updated Part B conclusion.

Packaging Changes & CPSR Validity

Switching from glass to plastic, or between plastic types, feels like a straightforward operational decision. Under EU cosmetic law, it is also a safety question that directly affects your cosmetic product safety report.

Packaging material interacts with your formula in ways that matter scientifically:

• • pH stability over the product’s shelf life

• • Preservation efficacy in the new container

• • Potential for chemical migration from the packaging into the product

Changing packaging materials may affect:

• • Formula stability

• • Preservation performance

• • Chemical migration risk

• • Shelf-life behavior

• • Product contamination risk

Common examples include:

• • Glass to plastic conversions

• • New airless packaging systems

• • Recycled plastic usage

• • Supplier changes

• • Pump mechanism modifications

All of this is assessed in Part A of your CPSR. Change the packaging and that data no longer applies, even if the formula is completely unchanged. Your Safety Assessor needs new stability and compatibility data generated with the new packaging before they can stand behind their Part B conclusion. 

Skipping this step is a compliance gap, and market surveillance inspections are specifically trained to identify it.

What Are the Real Consequences of Not Updating Your CPSR?

The consequences of falling behind on CPSR compliance are not theoretical. National market surveillance authorities across the EU actively inspect products, request PIF documentation, and take enforcement action. Here is what that looks like in practice.

1. 1. Mandatory product withdrawal. If your CPSR does not reflect current EU regulation, authorities can require you to remove your product from the market immediately, at your cost.

1. 1. Financial penalties. Each EU member state sets its own penalty framework for cosmetics regulation breaches. Fines can be substantial for persistent or knowing non-compliance.

1. 1. CPNP suspension. A product notification can be flagged as non-compliant, making it unlawful to continue selling until the documentation is corrected and resubmitted.

1. 1. Platform delisting. Major e-commerce platforms operating in the EU, including Amazon EU, have compliance teams that monitor regulatory updates. They can delist your products without warning when documentation does not hold up to scrutiny.

1. 1. Reputational damage. A product withdrawal or enforcement action creates brand credibility problems that are far harder to recover from than the cost of keeping your documentation current in the first place.

CPSR Compliance Update Checklist: Use This Every 6 Months

How Often Should Cosmetic Brands Review Their CPSR?

Best practice is reviewing cosmetic compliance every six months. However, brands should conduct immediate reviews whenever:

• • EU regulations change

• • SCCS opinions are published

• • Ingredients become restricted

• • Packaging changes occur

• • Formula modifications happen

• • Claims or usage instructions change

Proactive compliance is far less expensive than emergency corrective action after enforcement begins. 

Final Thoughts:

A cosmetic product safety report is not a certificate you earn once. It is a live document that carries legal weight every single day your product is on the EU market.

EU cosmetic regulation changes regularly. Ingredient restrictions tighten. Scientific standards evolve. The brands that stay compliant are not the ones who react fastest when enforcement arrives; they are the ones who built a system to stay ahead of it.

Work with a Safety Assessor who monitors regulatory changes. Subscribe to SCCS opinions and European Commission cosmetics legislation updates. Run a compliance review every six months using the checklist above. And the next time an Omnibus regulation is published, you will not be scrambling, because your CPSR compliance will already be in order.

FAQs: 

What is a CPSR in the EU?

A Cosmetic Product Safety Report (CPSR) is a mandatory technical document required under EU Regulation (EC) No 1223/2009 for every cosmetic product sold on the EU market. It contains a full safety information dossier (Part A) and a qualified Safety Assessor’s conclusion that the product is safe (Part B). Without a valid, current CPSR, a product cannot legally be sold in the EU.

What is CPSR validity and how long does it last?

CPSR validity depends on whether the report accurately reflects your current formula, packaging, conditions of use, and the current EU regulatory requirements for every ingredient it contains. Any change to any of those factors, whether driven by your brand or by a regulatory update, means the CPSR needs reviewing and potentially updating.

What is the EU regulation for cosmetic products?

The primary legislation is EU Regulation (EC) No 1223/2009 on cosmetic products. It sets out all requirements for safety assessment, labelling, notification, and market surveillance. It is regularly amended through Omnibus regulations that update the ingredient Annexes. The most recent is Omnibus VIII, applicable from May 2026.

What happens if an EU cosmetic regulation is not implemented?

If a brand fails to comply, including failing to update their CPSR cosmetics documentation when required, the product can be legally withdrawn from the EU market, the brand may face financial penalties from national authorities, and the product’s CPNP notification can be suspended. Ignorance of a regulatory change is not a legal defence under EU law.

Do I need a new CPSR for every product variant?

If variants share the same base formula and the same safety profile, for example, the same moisturiser in different shades using permitted colorants, one cosmetic safety assessment may cover all variants. However, any variant with a meaningfully different formula, fragrance, or ingredient set requires its own assessment. Your Safety Assessor makes this determination based on the actual formulation data.